Effects of two new aldose reductase inhibitors, AL-1567 and AL-1576, in diabetic rats
- 1 May 1987
- journal article
- research article
- Published by Elsevier in Metabolism
- Vol. 36 (5) , 486-490
- https://doi.org/10.1016/0026-0495(87)90048-5
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Characterization of the reduction of 3-acetylpyridine adenine dinucleotide phosphate by benzyl alcohol catalyzed by aldose reductaseArchives of Biochemistry and Biophysics, 1986
- The effects of a new aldose reductase inhibitor (tolrestat) in galactosemic and diabetic ratsMetabolism, 1985
- Properties of ICI 128,436, a novel aldose reductase inhibitor, and its effects on diabetic complications in the ratMetabolism, 1985
- The Pharmacology of Aldose Reductase InhibitorsAnnual Review of Pharmacology and Toxicology, 1985
- A controlled trial of sorbinil, an aldose reductase inhibitor, in chronic painful diabetic neuropathyDiabetes, 1983
- Red cell sorbitol: an indicator of diabetic controlDiabetes, 1980
- CP-45,634: A novel aldose reductase inhibitor that inhibits polyol pathway activity in diabetic and galactosemic ratsMetabolism, 1979
- Polyol Accumulation in Galactosemic and Diabetic Rats: Control by an Aldose Reductase InhibitorScience, 1973
- The Sorbitol Pathway and the Complications of DiabetesNew England Journal of Medicine, 1973
- Identification of sorbitol in mammalian nerveBiochemical and Biophysical Research Communications, 1966